ZA907130B - Colestyramine as products containing lipid-lowering agents - Google Patents
Colestyramine as products containing lipid-lowering agentsInfo
- Publication number
- ZA907130B ZA907130B ZA907130A ZA907130A ZA907130B ZA 907130 B ZA907130 B ZA 907130B ZA 907130 A ZA907130 A ZA 907130A ZA 907130 A ZA907130 A ZA 907130A ZA 907130 B ZA907130 B ZA 907130B
- Authority
- ZA
- South Africa
- Prior art keywords
- colestyramine
- products containing
- lowering agents
- containing lipid
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3930168A DE3930168A1 (en) | 1989-09-09 | 1989-09-09 | Pharmaceutical compsn. contg. colestyramine to reduce lipid - in micro:tablet form levels without unpleasant taste |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA907130B true ZA907130B (en) | 1992-05-27 |
Family
ID=6389097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA907130A ZA907130B (en) | 1989-09-09 | 1990-09-07 | Colestyramine as products containing lipid-lowering agents |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE3930168A1 (en) |
MX (1) | MXPA92003517A (en) |
ZA (1) | ZA907130B (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2637668T1 (en) | 2010-11-08 | 2016-11-30 | Albiero Ab | Ibat inhibitors for the treatment of liver diseases |
KR20220082931A (en) | 2014-06-25 | 2022-06-17 | 이에이 파마 가부시키가이샤 | Solid preparation, and method for preventing or reducing discoloration thereof |
EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
JP6954927B2 (en) * | 2016-02-09 | 2021-10-27 | アルビレオ・アクチボラグ | Oral cholestyramine preparation and its use |
CN108601744B (en) * | 2016-02-09 | 2022-01-04 | 阿尔比里奥公司 | Oral cholestyramine formulations and uses thereof |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
CN110996915B (en) * | 2017-08-09 | 2023-10-03 | 阿尔比里奥公司 | Cholestyramine pellet, oral cholestyramine preparation and application thereof |
CN111032019B (en) * | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | Cholestyramine granules, oral cholestyramine preparation and application thereof |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
TW202015699A (en) | 2018-06-05 | 2020-05-01 | 瑞典商艾爾比瑞歐公司 | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
WO2019245449A1 (en) | 2018-06-20 | 2019-12-26 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
CA3158276A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
CR20220315A (en) | 2019-12-04 | 2022-10-26 | Albireo Ab | BENZOTI(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
JP2023504644A (en) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | Benzothiadiazepine compounds and their use as bile acid modulators |
JP2023537285A (en) | 2020-08-03 | 2023-08-31 | アルビレオ・アクチボラグ | Benzothia(di)azepine compounds and their use as bile acid modulators |
KR20230106651A (en) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | Odevixivat for the treatment of progressive familial intrahepatic cholestasis (PFIC) |
EP4255565A1 (en) | 2020-12-04 | 2023-10-11 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
-
1989
- 1989-09-09 DE DE3930168A patent/DE3930168A1/en not_active Withdrawn
-
1990
- 1990-09-07 MX MXPA92003517A patent/MXPA92003517A/en unknown
- 1990-09-07 ZA ZA907130A patent/ZA907130B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE3930168A1 (en) | 1991-03-14 |
MXPA92003517A (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA907130B (en) | Colestyramine as products containing lipid-lowering agents | |
GB9025491D0 (en) | Pharmaceutical compositions | |
GB9004016D0 (en) | Pharmaceutical compositions | |
GB8909022D0 (en) | Pharmaceutical compositions | |
AP9000232A0 (en) | Formulation | |
GB8916072D0 (en) | Pharmaceutical compositions | |
GB8914791D0 (en) | Formulation | |
GB2232891B (en) | Pharmaceutical composition | |
HUT56269A (en) | Pharmaceutical compositions | |
GB8916071D0 (en) | Pharmaceutical compositions | |
GB8909906D0 (en) | Pharmaceutical compositions | |
IE892701L (en) | Medianal products | |
GB8913170D0 (en) | Formulation | |
GB8911554D0 (en) | Formulation | |
GB8908248D0 (en) | Formulation | |
GB8926629D0 (en) | Formulation | |
GB8926252D0 (en) | Formulation | |
GB8909880D0 (en) | Pharmaceutical compositions | |
IE894216L (en) | Pharmaceutical compositions | |
IE892802L (en) | Pharmaceutical compositions | |
GB8927109D0 (en) | Pharmaceutical compositions | |
IE891521L (en) | Pharmaceutical compositions | |
GB8922129D0 (en) | Pharmaceutical compositions | |
GB8919447D0 (en) | Pharmaceutical compositions | |
IE892803L (en) | Pharmaceutical compositions |